HHLA2 promotes immune evasion in EGFR-mutant lung cancer by inhibiting CD8(+) T cell glutamine metabolism via KIR3DL3 interaction. Wu F, Shen J, Zhao Z, Chen Y, et al. Cancer Lett 2025;639:218219.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu F, Shen J, Zhao Z, Chen Y, et al. HHLA2 promotes immune evasion in EGFR-mutant lung cancer by inhibiting CD8(+) T cell glutamine metabolism via KIR3DL3 interaction. Cancer Lett 2025;639:218219.
PMID: 41391682